Journal Guide

Neurotherapeutics® is the journal of the American Society for Experimental NeuroTherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders, written by international authorities.  The Journal also includes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field. Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues. Future Issue ThemesJanuary 2013 - Multiple Sclerosis
Guest Editor: Rohit Bakshi (BWH/Harvard)April 2013 - Mitochondrial Mechanisms in Neurologic Disease
Guest Editor: Andrea Gropman (Children’s National Medical Center) July 2013 - Protein Misfoldi

OncoTargets and Therapy is an international, peer-reviewed journal focusing on the pathological basis of all cancers, potential targets for therapy and treatment protocols employed to improve the management of cancer patients. In terms of therapy, palliative care is also included as part of the overall patient care process. The journal will also focus on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction. This journal explores the evidence behind new and existing therapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.

OpenNano is an internationally peer-reviewed and open access journal publishing high-quality review articles and original research papers on the burgeoning area of nanopharmaceutics and nanosized delivery systems for drugs, genes, and imaging agents. The Journal publishes basic, translational and clinical research as well as methodological papers and aims to bring together chemists, biochemists, cell biologists, material scientists, pharmaceutical scientists, pharmacologists, clinicians and all others working in this exciting and challenging area.

The official journal of Orphanet, the European portal for rare diseases and orphan drugs Orphanet Journal of Rare Diseases is an open access, online journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high quality reviews solicited from experts in the field and also considers research on new syndromes and results of clinical trials of exceptional interest.

PharmaNutrition is the truly multidisciplinary home for preclinical and clinical researchers in academia and industry, working at or close to the interface of nutritional and pharmacological treatment concepts: where “nutrition” (food, food ingredients, specialized enteral and parenteral nutrition) and “pharma” (pharmacological intervention, clinical studies) meet, including the combination of the two.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, presents papers which describe innovative research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of papers published here. Current emphasis of the journal includes the following areas: preformulation; drug delivery and targeting; formulation design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics, among others. Pharmaceutical Research publishes twelve issues a year.

Pharmaceutical Statistics is an industry-led initiative, tackling real problems in statistical applications. The Journal publishes papers that share experiences in the practical application of statistics within the pharmaceutical industry. It covers all aspects of pharmaceutical statistical applications from discovery, through pre-clinical development, clinical development, post-marketing surveillance, consumer health, production, epidemiology, and health economics. The Journal is both international and multidisciplinary. It includes high quality practical papers, case studies and review papers. The aims of the Journal are to: